Non-invasive prenatal testing

Chromosomal changes in the foetus can be determined non-invasively from the blood sample of the mother by analysing the cell-free foetal DNA. Testing can be done starting from week 10 of the pregnancy and it does not entail any risk of pregnancy loss.

The results of prenatal test MaterniT21™ PLUS are available in five days from the arrival of the samples to the laboratory. The results include detailed information on the karyotype of the foetus.

MaterniT21^TMPLUS test

MaterniT21^TMPLUS test can be used to determine foetal chromosomal disorders: Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau syndrome (Trisomy 13), Trisomy 22 and 16, as well as sex chromosome abnormalities and seven syndromes caused by the deletion of small parts of chromosomes (microdeletions). Optionally, the gender of the foetus can also be determined.

Advantages of MaterniT21^TMPLUS compared to analogous tests:

clear YES/NO answer to whether the foetus has a chromosomal abnormality or not
minimal need for a repeat sample (number of samples without a result < 1.5%)
the test recognises chromosomal abnormalities even with a multiple pregnancy
enables to also determine Trisomy 16 and 22
possible to determine the most changes caused by microdeletions

We recommend doing the test starting from week 10 of the pregnancy. In case there is a wish to terminate the pregnancy, testing should be done before week 21 of the pregnancy.

The health examination includes genetic testing of blood and a consultation with a doctor.

The test is performed by Sequenom Laboratories in the United States.

If during the examination any health risks are discovered, you will be referred to a geneticist for a more detailed consultation, if necessary.

The price of the health examination at Medita Clinic is 496 euros.

Further information about the test

Medita Clinic offers women the MaterniT21^TMPLUS test in collaboration with Asper Biogene Laboratory.